Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2014
Volume 2014 eBook
Issue 2

A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.

 

A global contract manufacturer of biologics discusses the increasing impact of health-based exposure limits in assessing cross-contamination risks.

Download

Pharmaceutical Technology’s 2014 Bioprocessing and Sterile Manufacturing eBook

.

 

 

 

 

 

 

 

Articles in this issue
Continious-Biopharma185.jpg
Potential Benefits Drive Interest in Continuous Manufacturing
stephaniedubois200.jpg
Continuous Bioprocessing Challenges
PTebook0514_Cross-Contamination185.jpg
Determining Cross-Contamination Risks in Multiproduct Biopharmaceutical Facilities
PTebook0514_Continuous-Monitoring_1851431659146699.jpg
Achieving and Maintaining Compliance Using Continuous Monitoring Systems
PTebook0514_Telstar185.jpg
Optimizing the Sterilization of Liquids in Sealed Containers
par-almhelm200.jpg
Using Modular Systems in Biopharmaceutical Manufacturing
PTebook_Genzyme185.jpg
Determining Protein Oxidation Induced During Fill-Finish Operations
PTebook0514_SingleUse_185.jpg
Single-Use Technology in Parenteral Fill/Finish
Recent Videos
Pharm Tech Group looks at the challenges surrounding the development and manufacture of ATMPs in more detail with Agne Vaitkeviciene, CEO of Memel Biotech.
Pharm Tech Group sits down with Bernard Sagaert, CEO of etherna, to examine the role of mRNA in the treatment of autoimmune diseases.
Pharm Tech Group chats with Dr. Monika Paulė, CEO and co-founder of Caszyme about the evolution of CRISPR.
Related Content
Antibody colored by heavy and light chains against black background; glycosylated immunoglobulin in pink | Image Credit: ©Eric H Cheung-Stock.Adobe.com

Glycosylation Analysis for Multispecifics

Cynthia A. Challener
October 2nd 2024
Article

The best strategy is to use a combination of complementary methods.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

High Angle Shot of a Working Desk of a Successful Person in Office with Cityscape Window View. | Image Credit: © Gorodenkoff - stock.adobe.com

Responding to Mpox

Mike Hennessy Jr.
September 3rd 2024
Article

A coordinated and international response is needed to help control the latest mpox outbreak in Africa.

Drug Solutions Podcast: mRNA Past, Present, and Future

Drug Solutions Podcast: mRNA Past, Present, and Future

Chris Spivey
August 17th 2023
Podcast

An mRNA conversation about the recent past, current hot topics, and probable future.

GEA’s NexGen Press line of tablet presses | Image Credit: © GEA Pharma & Healthcare

Next-Generation Tablet Press

Pharmaceutical Technology Editors
August 1st 2024
Article

The NexGen Press 45 is the latest member of GEA Pharma & Healthcare’s NexGen Press line of tablet presses.

Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

First Approved Stelara Biosimilar Launched in Europe by STADA and Alvotech

Feliza Mirasol
July 30th 2024
Article

STADA and Alvotech have launched Uzpruvo in Europe, making it the first approved biosimilar to Stelara (ustekinumab) in the European market.